Novavax Files 8-K: Regulation FD Disclosure
Ticker: NVAX · Form: 8-K · Filed: Apr 23, 2025 · CIK: 1000694
| Field | Detail |
|---|---|
| Company | Novavax Inc (NVAX) |
| Form Type | 8-K |
| Filed Date | Apr 23, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulation-fd, disclosure
TL;DR
Novavax dropped an 8-K, likely with news. Check the full filing.
AI Summary
On April 23, 2025, Novavax, Inc. filed an 8-K report. The filing indicates a Regulation FD Disclosure, suggesting the company is releasing material non-public information to the public. Specific details regarding the nature of this disclosure, such as financial figures or significant business events, are not provided in the excerpt.
Why It Matters
This filing signals Novavax is making a public disclosure of information that could impact investors. Investors should review the full filing for details on the nature of the disclosure.
Risk Assessment
Risk Level: medium — Regulation FD disclosures often precede significant news that can impact stock price, requiring investor attention.
Key Players & Entities
- NOVAVAX INC (company) — Registrant
- April 23, 2025 (date) — Date of Report
- 240-268-2000 (phone_number) — Registrant's telephone number
FAQ
What is the specific nature of the Regulation FD Disclosure made by Novavax, Inc. on April 23, 2025?
The provided excerpt does not specify the nature of the Regulation FD Disclosure; it only indicates that such a disclosure was made.
What is Novavax, Inc.'s principal executive office address?
Novavax, Inc.'s principal executive offices are located at 700 Quince Orchard Road, Gaithersburg, Maryland 20878.
What is the Commission File Number for Novavax, Inc.?
The Commission File Number for Novavax, Inc. is 0-26770.
What is the I.R.S. Employer Identification No. for Novavax, Inc.?
The I.R.S. Employer Identification No. for Novavax, Inc. is 22-2816046.
Under which section of the Securities Exchange Act of 1934 is this Form 8-K filed?
This Form 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 23, 2025 regarding NOVAVAX INC (NVAX).